Iopromide Injection Shortage

• • Ultravist injection, Bayer, 240 mg iodine/ mL, 100 mL vial, 1 count, NDC 50419-0342-10 - discontinued
  • Ultravist injection, Bayer, 300 mg iodine/ mL, 125 mL vial, 1 count, NDC 50419-0344-12
  • Ultravist injection, Bayer, 300 mg iodine/ mL, 150 mL vial, 1 count, NDC 50419-0344-15
  • Ultravist injection, Bayer, 370 mg iodine/ mL, 150 mL vial, 1 count, NDC 50419-0346-15
  • Ultravist injection, Bayer, 370 mg iodine/ mL, 200 mL vial, 1 count, NDC 50419-0346-20

• • Bayer did not provide a reason for the shortage.

• • Ultravist injection, Bayer, 300 mg iodine/ mL, 100 mL vial, 1 count, NDC 50419-0344-10
  • Ultravist injection, Bayer, 300 mg iodine/ mL, 50 mL vial, 1 count, NDC 50419-0344-05
  • Ultravist injection, Bayer, 370 mg iodine/ mL, 100 mL vial, 1 count, NDC 50419-0346-10
  • Ultravist injection, Bayer, 370 mg iodine/ mL, 50 mL vial, 1 count, NDC 50419-0346-05

Estimated Resupply Dates

• • Bayer has Ultravist 300 mg of iodine/mL in 125 mL and 150 mL vials and 370 mg of iodine/mL in 150 mL and 200 mL vials on back order and the company cannot estimate release dates.